导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.28% | 1159/2255 |
| 近一周 | -1.47% | 2016/2318 |
| 近一月 | 2.29% | 503/2314 |
| 近一季 | -4.38% | 1896/2311 |
| 近半年 | 19.24% | 1008/2291 |
| 近一年 | 22.39% | 991/2249 |
| 近两年 | 48.65% | 406/2172 |
| 近三年 | 58.95% | 124/2050 |
| 成立以来 | 21.05% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
3.92% 703/2331 |
2.54% 809/2353 |
17.88% 1143/2347 |
- - |
| 2024 | 26.12% 55/2336 |
-5.17% 1658/2322 |
-0.55% 1013/2326 |
11.36% 683/2322 |
20.09% 25/2336 |
| 2023 | 4.53% 116/2330 |
14.20% 117/2290 |
-1.85% 1088/2303 |
-4.72% 1101/2318 |
-2.12% 897/2330 |
| 2022 | -14.07% 940/2299 |
-3.84% 485/2227 |
17.36% 97/2269 |
-19.18% 2167/2294 |
-5.78% 1916/2300 |
| 2021 | -5.14% 1811/2205 |
-11.49% 1876/2009 |
13.78% 542/2060 |
-10.87% 1868/2103 |
5.69% 452/2208 |
| 2020 | -3.97% 1956/2086 |
-5.49% 1559/1861 |
5.54% 1407/1950 |
-9.31% 1944/2010 |
6.16% 1225/2031 |
| 2019 | 25.45% 1007/1974 |
27.97% 607/3054 |
-9.09% 2926/3201 |
0.21% 1648/1861 |
7.62% 777/1886 |
| 2018 | - - |
- - |
- - |
- - |
-15.40% 2729/2977 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 先锋聚利混合C VS. () |